Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The goal of anti-HIV therapy is to prevent HIV from replicating. Long-term control of HIV
requires at least two anti-HIV drugs that are active against the virus. Drug resistance is a
problem for many treatment-experienced, HIV-infected people. The purpose of this study was to
determine the benefit of adding a nucleoside reverse transcriptase inhibitor (NRTI) to a new
anti-HIV drug regimen for the suppression of HIV.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)